AbCellera Biologics Inc. (ABCL)
AbCellera Biologics Inc. specializes in pioneering an advanced platform for the discovery of antibodies. This comprehensive, AI-driven system meticulously explores and analyzes natural immune systems to identify antibodies suitable for the creation of new pharmaceutical drugs. As of December 31, 2021, the company had cultivated 156 discovery programs, ranging from completed to in-progress or under contract, in partnership with 36 entities. Notably, AbCellera maintains a crucial research collaboration and license agreement with Eli Lilly and Company. Founded in 2012, the firm is headquartered in Vancouver, Canada.
Sector: Pharmaceutical Preparations
Industry: Biotechnology
AbCellera Biologics Inc.
NASDAQ:ABCLHealthcare · Biotechnology
-6.19%$12.27
AH$12.20-0.57%vs close
Mkt Cap$3.98B
Float212.82M
O/S324.05M
Vol
$ Vol
RVOL
Inst Own35.2%
SI14.5%
Earnings
Dilution
Financials Summary
Revenue$75.13M
Net Income-$146.41M
Total Assets$1.36B
Free Cash Flow-$174.07M
Debt & Equity
Debt 13%
Equity 87%
Total Debt$143.22M
Total Equity$966.9M
Shares Outstanding
Short Interest
Split History
No splits on record
Nothing in ABCL's public trading history: no forward or reverse split has affected the share count.
Balance Sheet Details
Assets$1.36B
Liabilities$390.05M
Accounts Receivable$153.4M
Accounts Payable$25.23M
Inventory$6.34M
PP&E (Net)$428M
Goodwill$47.81M
Intangible Assets$38.38M
Income Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Revenue | $75.13M | $28.83M | $38.02M | $485.42M | $375.2M | $233.16M | $11.61M | $8.83M |
| YoY Growth | 160.6% | -24.2% | -92.2% | 29.4% | 60.9% | 1907.9% | 31.5% | - |
| Cost of Revenue | $28.82M | $0 | $0 | $66.44M | $45.52M | $27.14M | $0 | $0 |
| Gross Profit | $46.31M | $28.83M | $38.02M | $418.99M | $329.69M | $206.01M | $11.61M | $8.83M |
| Gross Margin | 61.6% | 100.0% | 100.0% | 86.3% | 87.9% | 88.4% | 100.0% | 100.0% |
| Research and Development | $186.83M | $167.26M | $175.66M | $107.88M | $62.06M | $29.39M | $10.11M | $5.8M |
| Selling, General, and Administrative | $76.58M | $85.49M | $75.18M | $66.75M | $48.76M | $15.75M | $4.01M | $2.86M |
| Other | $0 | $90.85M | $24.39M | $27.84M | $14.45M | $4.84M | $1.6M | $918K |
| Total Operating Expenses | $263.41M | $343.6M | $275.23M | $202.48M | $125.27M | $49.98M | $15.73M | $9.58M |
| Operating Income (EBIT) | -$217.1M | -$314.77M | -$237.21M | $216.51M | $204.41M | $156.03M | -$4.12M | -$753K |
| Operating Margin | -289.0% | -1091.7% | -623.8% | 44.6% | 54.5% | 66.9% | -35.5% | -8.5% |
| Interest Expense | $0 | $0 | $0 | $4.04M | $5.22M | $6.51M | $209K | $212K |
| Interest Income | $28.33M | $38.47M | $42.25M | $16.08M | $3.33M | $293K | $155K | $42K |
| Other Income (Expense) | $39.51M | $114.37M | $63.18M | $22.59M | $14.74M | $1.8M | $1.91M | $1.06M |
| Income Before Tax (EBT) | -$177.59M | -$200.4M | -$174.03M | $239.1M | $219.15M | $157.83M | -$2.21M | $309K |
| Income Tax Expense | -$31.18M | -$37.54M | -$27.63M | $80.58M | $65.69M | $38.91M | $0 | $0 |
| Net Income | -$146.41M | -$162.86M | -$146.4M | $158.52M | $153.46M | $118.92M | -$2.21M | $309K |
| Net Income Margin | -194.9% | -564.8% | -385.0% | 32.7% | 40.9% | 51.0% | -19.0% | 3.5% |
| Supplementary Data | ||||||||
| EPS | -0.49 | -0.55 | -0.51 | 0.56 | 0.56 | 0.45 | -0.01 | 0.00 |
| Diluted EPS | -0.49 | -0.55 | -0.51 | 0.50 | 0.48 | 0.45 | -0.01 | 0.00 |
| Weighted Average OS | 298.71M | 294.33M | 289.17M | 285.06M | 275.76M | 263.13M | 215.41M | 151.04M |
| EBITDA | -$148.77M | -$204.15M | -$192.16M | $260.17M | $239.15M | $169.62M | -$155K | $1.44M |
| EBITDA Margin | -198.0% | -708.0% | -505.3% | 53.6% | 63.7% | 72.7% | -1.3% | 16.3% |
Balance Sheet
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Assets | ||||||||
| Current Assets | ||||||||
| Cash and Cash Equivalents | $128.51M | $156.32M | $133.32M | $386.54M | $476.14M | $594.12M | $7.55M | $10.44M |
| Short-Term Investments | $405.31M | $469.29M | $627.26M | $499.95M | $246.84M | $0 | $0 | $0 |
| Cash and Short-Term Investments | $533.83M | $625.61M | $760.59M | $886.49M | $722.98M | $594.12M | $7.55M | $10.44M |
| Accounts Receivable | $153.4M | $92.13M | $64.38M | $103.41M | $174.86M | $213.73M | $2.12M | $1.4M |
| Inventory | $6.34M | $0 | $1.11M | $1.53M | $1.67M | $1.41M | $163K | $0 |
| Other Current Assets | $34.67M | $33.63M | $45.91M | $25M | $25M | $0 | $2.25M | $2.76M |
| Total Current Assets | $728.23M | $751.37M | $871.99M | $1.03B | $929.8M | $813.33M | $12.64M | $15.16M |
| Long-Term Assets | ||||||||
| Property, Plant & Equipment Net | $428M | $340.43M | $287.7M | $217.25M | $111.62M | $17.92M | $8.48M | $6.33M |
| Goodwill | $47.81M | $47.81M | $47.81M | $47.81M | $47.81M | $31.5M | $0 | $0 |
| Intangible Assets | $38.38M | $42.11M | $120.42M | $131.5M | $148.39M | $115.15M | $0 | $0 |
| Long-Term Investments | $62.58M | $82.3M | $65.94M | $72.52M | $50.31M | $20.03M | $0 | $0 |
| Deferred Tax Assets | $0 | $0 | $0 | $5.3M | $7.41M | $5.9M | $0 | $0 |
| Other Long-Term Assets | $51.95M | $96.54M | $94.24M | $41.03M | $23.23M | $1.71M | $2.37M | $0 |
| Total Long-Term Assets | $628.72M | $609.18M | $616.11M | $515.42M | $388.77M | $192.21M | $10.85M | $6.33M |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $1.36B | $1.36B | $1.49B | $1.54B | $1.32B | $1.01B | $23.49M | $21.49M |
| Liabilities | ||||||||
| Current Liabilities | ||||||||
| Accounts Payable | $25.23M | $34.35M | $25.51M | $14.83M | $14.92M | $7.32M | $1.64M | $1.52M |
| Short-Term Debt | $0 | $0 | $0 | $0 | $0 | $190K | $2.47M | $2.53M |
| Current Income Tax Payable | $0 | $0 | $0 | $0 | $35.68M | $36.15M | $0 | $0 |
| Current Unearned Revenue | $22.51M | $21.18M | $18.96M | $21.61M | $7.54M | $7.53M | $0 | $2.33M |
| Other Current Liabilities | $0 | $8.09M | $60.68M | $69.84M | $54.85M | $9.08M | $3.37M | $50K |
| Total Current Liabilities | $64.31M | $76.61M | $119.01M | $118.32M | $120.68M | $103.49M | $7.89M | $6.43M |
| Long-Term Liabilities | ||||||||
| Long-Term Debt | $0 | $0 | $0 | $0 | $0 | $2.2M | $1.36M | $911K |
| Long-Term Unearned Revenue | $174.45M | $155.59M | $104.11M | $60.32M | $60.76M | $25.89M | $0 | $2.26M |
| Long-Term Deferred Tax Liabilities | $9.12M | $10.05M | $30.61M | $33.18M | $37.37M | $26.16M | $0 | $0 |
| Other Long-Term Liabilities | $4.77M | $1.47M | $10.82M | $19.14M | $37.62M | $13.57M | $1.34M | $277K |
| Total Long-Term Liabilities | $325.74M | $227.86M | $216.76M | $189.31M | $172.16M | $71.54M | $5.34M | $3.45M |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $390.05M | $304.47M | $335.78M | $307.63M | $292.84M | $175.03M | $13.24M | $9.88M |
| Stockholders' Equity | ||||||||
| Preferred Stock | $0 | $0 | $0 | $0 | $0 | $0 | $7.55M | $7.56M |
| Common Stock | $802.34M | $777.17M | $753.2M | $734.37M | $722.43M | $710.39M | $5.12M | $5.07M |
| Retained Earnings | -$29.48M | $116.93M | $279.79M | $426.19M | $267.67M | $114.2M | -$4.72M | -$2.5M |
| Comprehensive Income & Other | -$4.23M | -$4.38M | -$1.72M | -$1.39M | $280K | $0 | $0 | $0 |
| Other Stockholders' Equity | $194.04M | $161.98M | $119.33M | $72.73M | $35.64M | $5.92M | $9.85M | $9.04M |
| Total Equity | $966.9M | $1.06B | $1.15B | $1.23B | $1.03B | $830.51M | $10.25M | $11.61M |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $1.36B | $1.36B | $1.49B | $1.54B | $1.32B | $1.01B | $23.49M | $21.49M |
| Supplementary Data | ||||||||
| Total Debt | $143.22M | $65.36M | $77.38M | $82.26M | $40.06M | $6.78M | $6.89M | $3.44M |
| Net Debt | $14.71M | -$90.96M | -$55.94M | -$304.28M | -$436.08M | -$587.34M | -$662K | -$7M |
Cash Flow Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Operating Activities | ||||||||
| Net Income | -$146.41M | -$162.86M | -$146.4M | $158.52M | $153.46M | $118.92M | -$2.21M | $309K |
| Depreciation & Amortization | $28.82M | $97M | $30.89M | $33.1M | $17.25M | $5.27M | $1.85M | $918K |
| Deferred Income Tax | $0 | $0 | $1.96M | -$2.11M | -$2.02M | $2.1M | $0 | $0 |
| Stock-Based Compensation | $55.79M | $67.58M | $64.18M | $49.48M | $30.65M | $8.4M | $890K | $615K |
| Changes in Working Capital: | ||||||||
| Accounts Receivable | -$55.62M | -$75.12M | -$45.93M | -$22.71M | $22.48M | -$203.02M | -$1.8M | -$477K |
| Inventory | $0 | $0 | $18.25M | $0 | $0 | $0 | $0 | -$898K |
| Accounts Payable | $3.46M | $10.63M | -$15.1M | $1.07M | $1.4M | $6.6M | $150K | $180K |
| Other Working Capital | -$18.53M | $38.64M | $56.01M | $51.47M | $17.79M | $79.72M | $3.63M | $3.11M |
| Total Working Capital Change | -$70.69M | -$25.84M | $13.22M | $29.82M | $41.67M | -$116.7M | $1.97M | $1.91M |
| Other Non-Cash Items | $1.2M | -$84.44M | -$7.74M | $8.55M | $3.57M | $4.71M | $194K | -$188K |
| Net Cash from Operating | -$131.29M | -$108.56M | -$43.88M | $277.36M | $244.58M | $22.69M | $2.69M | $3.56M |
| Investing Activities | ||||||||
| Capital Expenditures | -$42.77M | -$78.4M | -$77.51M | -$72.66M | -$58.45M | -$9.67M | -$4M | -$5.31M |
| Acquisitions | -$7.14M | -$19.63M | -$13.69M | -$25.68M | -$11.46M | -$106.89M | $0 | $0 |
| Purchases of Investments | -$453.14M | -$765.09M | -$1.07B | -$781.35M | -$322.57M | $0 | $0 | $0 |
| Sales of Investments | $506.07M | $948.81M | $910.94M | $510.63M | $27.61M | $0 | $0 | $0 |
| Other Investing Activities | $84.72M | $35.71M | $25.31M | $16.43M | $32.62M | -$3.22M | -$1.78M | $0 |
| Net Cash from Investing | $87.75M | $121.41M | -$221.11M | -$352.63M | -$332.25M | -$119.78M | -$5.78M | -$5.31M |
| Financing Activities | ||||||||
| Debt Repaid | - | -$13.5M | -$11.59M | -$2.75M | $951K | -$85.54M | $206K | -$2.01M |
| Common Stock Issuance | $0 | $0 | $0 | $0 | $4.62M | $522.84M | $14K | $2.61M |
| Common Stock Repurchases | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | $14.08M | -$729K | -$1.23M | -$4.38M | -$7.55M | $1M | $25K | $37K |
| Net Cash from Financing | $14.08M | $12.77M | $10.36M | -$1.63M | -$3.89M | $683.65M | $195K | $12.19M |
| Forex Effect | $1.1M | -$2.62M | $589K | -$9.6M | -$1.43M | $0 | $0 | $283 |
| Net Change in Cash | -$28.37M | $23M | -$254.04M | -$86.49M | -$92.97M | $586.56M | -$2.89M | $10.44M |
| Supplementary Data | ||||||||
| Operating Cash Flow | -$131.29M | -$108.56M | -$43.88M | $277.36M | $244.58M | $22.69M | $2.69M | $3.56M |
| Capital Expenditure | -$42.77M | -$78.4M | -$77.51M | -$72.66M | -$58.45M | -$14.67M | -$4M | -$5.31M |
| Free Cash Flow | -$174.07M | -$186.95M | -$121.38M | $204.7M | $186.13M | $8.02M | -$1.3M | -$1.74M |
| Cash at Beginning | $183.62M | $160.61M | $414.65M | $501.14M | $594.12M | $7.55M | $10.44M | -$283 |
| Cash at End | $155.25M | $183.62M | $160.61M | $414.65M | $501.14M | $594.12M | $7.55M | $10.44M |